Egeiro Pharma SA
Ouverture de faillite 7.5 FTEThe score of Egeiro Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity +78 % Total assets +47 % Headcount (avg FTE) +53 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Egeiro Pharma's annual accounts
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue | 117,839 € | ||||
| Net result | −€1.57m | ||||
| Equity | €6.05m | ||||
| Cash | €1.15m | ||||
| EBITDA | −€1.11m | ||||
| Total assets | €7.53m |
Filed annual accounts
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
- Year ended 31 Dec 2020filed on 21 Jun 2021
- Year ended 31 Dec 2019filed on 17 Jul 2020
Egeiro Pharma's financial analysis
- Solvency80.3%sector median: 48.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Egeiro Pharma
Egeiro Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0684.906.013
- VAT number
- BE0684906013
- Peppol
- Not found on Peppol as of 04 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 22 Nov 2017
- Registered office
- 6041 Charleroi
- Size
- Micro · 7.5 FTE
- Latest accounts
- 2023 · filed on 08 Aug 2024
- Activity
- Manufacture of other inorganic basic chemicals (NACE 20130)
Egeiro Pharma (SA) has been based in Charleroi since 2017, active in: manufacture of other inorganic basic chemicals. For 2023, it reports revenue of 117,839 €, a net loss of €1.57m and equity of €6.05m. With 7.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 80.3%, above the median of its sector (48.2%).
Companies similar to Egeiro Pharma
Companies in the same business, of comparable size and area, outside its group.
- beLife Manufacture of other organic basic chemicals Engis · balance sheet €2.94m
- PVS Chemicals Belgium Manufacture of other inorganic basic chemicals Ghent · balance sheet €24.2m
- Dequachim Manufacture of other inorganic basic chemicals Saint-Ghislain · balance sheet €8.64m
- RdH Consulting Manufacture of other inorganic basic chemicals Uccle · balance sheet 371,830 €
- Silox Belgium Manufacture of other inorganic basic chemicals Engis · balance sheet €33.8m
- Solvay Chimie Manufacture of other inorganic basic chemicals Brussels · balance sheet €36.5m
- Silmaco Manufacture of other inorganic basic chemicals Lanaken · balance sheet €36.9m
- Schepens Manufacture of other chemical products n.e.c. Lummen · balance sheet €4.02m
Frequently asked questions about Egeiro Pharma
What is the revenue of Egeiro Pharma?
According to the 2023 annual accounts filed with the NBB, the revenue of Egeiro Pharma amounts to 117,839 €.
What is the VAT number of Egeiro Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0684906013 for Egeiro Pharma, if the company is VAT-registered. Its company number (CBE) is 0684.906.013.
Where is the registered office of Egeiro Pharma?
According to the CBE register, the registered office of Egeiro Pharma is in 6041 Charleroi.
What is the equity of Egeiro Pharma?
At the close of the 2023 financial year, the equity of Egeiro Pharma amounts to 6,049,198 €, a solvency of 80.3% of total assets.
How many people work at Egeiro Pharma?
7.5 full-time equivalents on average according to the 2023 social balance sheet.
Who manages Egeiro Pharma?
The register lists 5 active mandates at Egeiro Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Egeiro Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →